Manufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Peter Weissberg, Xcenda, an AmerisourceBergen Company
Advertisement
Articles by Peter Weissberg, Xcenda, an AmerisourceBergen Company
Advertisement
Latest Updated Articles
- ACOs raise the stakes for evidence-based medicine
Published: March 9th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
4
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
5
